Teicoplanin Dosing for Prosthetic Bone Infection with CrCl 34 mL/min and Weight 61 kg
For this 61 kg patient with prosthetic bone infection and CrCl 34 mL/min, administer teicoplanin with a loading dose of 6-12 mg/kg IV every 12 hours for 3 doses (366-732 mg per dose), followed by a maintenance dose of 6-12 mg/kg IV once daily (366-732 mg daily), with the loading dose unchanged despite renal impairment but the maintenance interval potentially extended based on therapeutic drug monitoring. 1
Loading Dose Regimen
- Administer the full loading dose of 6-12 mg/kg IV every 12 hours for 3 doses regardless of renal function, as loading doses are not affected by alterations in renal clearance 2, 1
- For this 61 kg patient, this translates to 366-732 mg IV every 12 hours for 3 doses 1
- Higher loading doses (10-12 mg/kg) are specifically recommended for complicated infections including osteomyelitis, making 610-732 mg per dose the preferred range for prosthetic bone infection 1, 2
- The loading regimen is critical because teicoplanin is 90% protein-bound and penetrates slowly into tissues, requiring aggressive initial dosing to achieve therapeutic levels 3
Maintenance Dose Adjustments for Renal Impairment
- After the 3 loading doses, begin maintenance dosing at 6-12 mg/kg (366-732 mg) IV once daily initially 1, 2
- Clearance is reduced predictably in renal failure, and dosage adjustments should be based on the ratio of impaired clearance to normal clearance 3
- With CrCl 34 mL/min (approximately 34% of normal), consider extending the maintenance interval to every 48-72 hours after the initial daily doses, particularly if trough levels exceed 20 mg/L 3
- For patients on hemodialysis (more severe impairment than this patient), maintenance doses every 72 hours produced adequate trough levels of 8 mg/L, suggesting this patient may need dosing every 36-48 hours 3
Therapeutic Drug Monitoring Strategy
- Target trough serum levels of 20-60 mg/L for serious bone infections 4
- Measure trough levels at 48-72 hours after starting therapy to guide maintenance dosing adjustments 5
- Bone concentrations reach 7 mg/L at 12 hours after a 6 mg/kg dose, but doses of 10 mg/kg are necessary to achieve adequate bone concentrations, supporting the higher end of the dosing range 3
- Monitoring is not necessary to avoid toxicity but is helpful to ensure therapeutic concentrations are present, especially in patients not responding to treatment 3
Duration and Combination Therapy
- Treat prosthetic bone infections for 4-6 weeks with pathogen-specific intravenous therapy 2
- Consider adding rifampin 300 mg PO every 8 hours if the organism is rifampin-susceptible, particularly for staphylococcal prosthetic infections 2
- Teicoplanin has demonstrated 91% clinical cure rates in chronic bone infections (mean duration 20.9 months) when used at 400 mg/day after loading 6
Safety Considerations in Renal Impairment
- Teicoplanin is eliminated predominantly by the kidneys (97-98% unchanged), making renal function the primary determinant of maintenance dosing 3
- The elimination half-life is prolonged to 83-168 hours in the terminal phase, which is further extended in renal impairment 3
- Adverse events occur in approximately 10% of patients but rarely require treatment discontinuation, with no increased toxicity observed at higher doses (600 mg vs 400 mg daily) 4, 6
- Potentially toxic levels are defined as >60 mg/L, but these occurred in only 6-8% of patients receiving higher doses without increased clinical toxicity 4
Practical Dosing Algorithm
- Day 1-2: Give 610-732 mg (10-12 mg/kg) IV every 12 hours for 3 doses 1
- Day 3-7: Give 610-732 mg IV once daily 1
- Day 4-5: Check trough level before the morning dose 5
- If trough <20 mg/L: Continue daily dosing 4
- If trough 20-60 mg/L: Continue daily dosing or extend to every 36-48 hours based on trend 3, 4
- If trough >60 mg/L: Extend interval to every 48-72 hours 3, 4
- Recheck levels weekly and adjust interval accordingly 3